Precigen, Inc. Common Stock (PGEN) Stock Price, Quote & AI Analysis

Live PGEN stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Precigen, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Precigen, Inc. Common Stock (PGEN), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

PGEN
Precigen, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
0.000000
High
0.000000
Low
0.000000
Volume
0
VWAP
-
Market Cap
$1,578,057,265.54
52W Range
$1.11 - $5.47
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
May 12, 2026 Q1
Market
EPS Estimate: $-0.0765
Revenue Estimate: $24,480,000.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Precigen, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Precigen, Inc. Common Stock Overview

Company information

Company Overview

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the following segments: Biopharmaceuticals, Exemplar, and Trans Ova. The Biopharmaceuticals segment is involved in advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. It also engages in pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics. The Exemplar segment is focused on developing research models and services for healthcare research applications. The Trans Ova segment provides bovine reproductive technologies. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Company Details
Market Cap
$1.30B
Shares Outstanding
353,929,000
Weighted Shares Outstanding
353,824,499
CEO
Helen Sabzevari
Address
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876
Employees
25
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Precigen, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...